Reprogramming activated astrocytes into GABAergic neurons to treat trigeminal neuralgia
Neurochemistry International · 2025
DOI: 10.1016/j.neuint.2025.106067 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurochemistry International, 2025. Verfasst von Shuangyin Xia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pain Management and Anesthesiology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China; Hunan Provincial Cli…. Hauptthemen laut MEDLINE: Trigeminal Neuralgia, Astrocytes, GABAergic Neurons, Cellular Reprogramming. Die Arbeit nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province, Central South University.
Abstract (Originalsprache)
Trigeminal neuralgia (TN) is the most common type of cranial neuralgia. Currently, there remains a significant gap in the availability of effective and safe treatment options in clinical practice. Transdifferentiation of proliferating activated astrocytes into inhibitory neurons is a potential therapeutic strategy for central nervous system diseases. GABAergic neurons are one of the most type of prevalent inhibitory neurons. This study aims to reprogram proliferating astrocytes in the spinal trigeminal subnucleus caudalis (SpVc) into GABAergic neurons, could improve neuronal excitation-inhibition balance, alleviate pain, which serve as a potential treatment for trigeminal neuralgia. A chronic constriction injury of the distal infraorbital nerve (CCI-dION) was induced in the infraorbital branch of the trigeminal nerve to create a rat model of TN. Adeno-associated viruses were used to overexpress transcription factors Sox2 and Mash1 in astrocytes. The changes in astrocytes and GABAergic neurons in the SpVc region were detected by immunofluorescence, Western blotting, qPCR, and electron microscopy. The mechanical pain threshold testing was used to assess rat TN. In the SpVc region of CCI-dION rats, astrocytes showed proliferation and activation, and the number of GABAergic neurons decreased significantly. Overexpressing Sox2 and Mash1 in astrocytes led to a significant transdifferentiation into GABAergic neurons, which - improved the mechanical pain threshold in CCI-dION rats. Furthermore, fluorocitrate-mediated astrocyte deactivation abolished both the neuronal reprogramming and the analgesic effects, underscoring the essential role of astrocytes in this process. These findings suggest that overexpressing Sox2 and Mash1 in astrocytes led to a significant transdifferentiation into GABAergic neurons, which significantly improved the mechanical pain threshold in CCI-dION rats. Thus, this approach has the potential to provide a new treatment for TN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pain Management and Anesthesiology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China; Hunan Provincial Clinical Research Center for Pain Medicine (No. 2023SK4039), Changsha, Hu…
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
- Central South University
Zitieren
APA
Xia, S., Chen, K., Li, X., Zou, D., Wang, M., & Wang, Y. (2025). Reprogramming activated astrocytes into GABAergic neurons to treat trigeminal neuralgia. Neurochemistry International. https://doi.org/10.1016/j.neuint.2025.106067
Vancouver
Xia S, Chen K, Li X, Zou D, Wang M, Wang Y. Reprogramming activated astrocytes into GABAergic neurons to treat trigeminal neuralgia. Neurochemistry International. 2025. doi:10.1016/j.neuint.2025.106067
BibTeX
@article{Xia2025,
author = {Xia, Shuangyin and Chen, Kai and Li, Xin and Zou, Dingquan and Wang, Meng and Wang, Yaping},
title = {Reprogramming activated astrocytes into GABAergic neurons to treat trigeminal neuralgia},
journal = {Neurochemistry International},
year = {2025},
doi = {10.1016/j.neuint.2025.106067}
}
EUVIMED